Artrya Limited (ASX:AYA)

Australia flag Australia · Delayed Price · Currency is AUD
0.7700
+0.0300 (4.05%)
Jun 6, 2025, 4:10 PM AEST
214.29%
Market Cap 83.56M
Revenue (ttm) 13.00K
Net Income (ttm) -14.56M
Shares Out 112.92M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100,133
Average Volume 112,421
Open 0.7300
Previous Close 0.7400
Day's Range 0.7300 - 0.7700
52-Week Range 0.2000 - 1.0400
Beta 0.30
RSI 58.35
Earnings Date May 23, 2025

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography scans which identifies and manages patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia. [Read more]

Sector Healthcare
Founded 2018
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol AYA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.